NUVO PHARMACEUTICALS
DEAD
Serial Number
88200468
Owner
Nuvo Pharmaceuticals Inc.Attorney
James R MenkerFiling Date
Nov 20, 2018
NUVO PHARMACEUTICALS Trademark
Serial Number: 88200468
NUVO PHARMACEUTICALS is a trademark filed by
Nuvo Pharmaceuticals Inc.
on November 20, 2018. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
James R Menker Holley & Menker, PA
PO Box 331937
Atlantic Beach
FL 32233
UNITED STATES
Trademark Details
Filing Date
November 20, 2018
Registration Date
Not Registered
Published for Opposition
April 21, 2020
Filing History
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 19, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 18, 2021 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 16, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 21, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 16, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 16, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 21, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 21, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 21, 2019 CNRT
ASSIGNED TO EXAMINER
Sep 30, 2019 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 31, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 31, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 4, 2019 GNRN
NON-FINAL ACTION E-MAILED
Mar 4, 2019 GNRT
NON-FINAL ACTION WRITTEN
Mar 4, 2019 CNRT
ASSIGNED TO EXAMINER
Feb 24, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2018 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 26, 2018 TCCA
NEW APPLICATION ENTERED
Nov 23, 2018 NWAP
